• 1
    Streffer JR, Bitzer M, Schabet M, et al. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology. 2001; 56: 1219-1221.
  • 2
    Boeker DK, Winking M. The role of boswellic acids in therapy of malignant glioma [in German]. Dt Aerztebl. 1997; 94: 1197-1199.
  • 3
    Ernst E. Frankincense: systematic review. B Med J. 2008; 337: a2813.
  • 4
    Reising K, Meins J, Bastian B, et al. Determination of boswellic acids in brain and plasma by high performance liquid chromatography/tandem mass spectrometry. Anal Chem. 2005; 77: 6640-6645.
  • 5
    Buchele B, Zugmaier W, Simmet T. Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high performance liquid chromatography. Identification of lupeolic acid, a novel pentacyclic triterpene. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 791: 21-30.
  • 6
    Ennet D, Poetsch F, Groditsch D. Indian frankincense. Dtsch Apoth Ztg. 2000; 140: 105-113.
  • 7
    Martinez D, Lohs K, Janzen J. Incense and myrrh: cultural history and economic impact, botany, chemistry, medicine [German]. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft mgH. 2009.
  • 8
    Poeckel D, Werz O. Boswellic acids: biological actions and molecular targets. Curr Med Chem. 2006; 13: 3359-3369.
  • 9
    Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006; 176: 3127-3140.
  • 10
    Kruger P, Daneshfar R, Eckert GP, et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos. 2008; 36: 1135-1142.
  • 11
    Poeckel D, Werz O. Boswellic acids: biological actions and molecular targets. Curr Med Chem. 2006; 13: 3359-3369.
  • 12
    Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006; 72: 1100-1116.
  • 13
    Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998; 3: 511-514.
  • 14
    Sander O, Herborn G, Rau R. Is H15 (resin extract of Boswellia serrata, “incense”) a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study [in German]. Z Rheumatol. 1998; 57: 11-16.
  • 15
    Gerhardt H, Seifert F, Buvari P, et al. Therapy of active Crohn disease with Boswellia serrata extract H 15 [in German]. Z Gastroenterol. 2001; 39: 11-17.
  • 16
    Madisch A, Miehlke S, Eichele O, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis. 2007; 22: 1445-1451.
  • 17
    Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee—a randomized double blind placebo controlled trial. Phytomedicine. 2003; 10: 3-7.
  • 18
    Sontakke S, Thawani V, Pimpalkhute P, et al. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of the knee. Indian Pharmacol. 2007; 39: 27-29.
  • 19
    Glaser T, Winter S, Groscurth P, et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer. 1999; 80: 756-765.
  • 20
    Evans ML, Graham MM, Mahler PA, Rasey JS. Use of steroids to suppress vascular response to radiation. Int J Radiat Oncol Biol Phys. 1987; 13: 563-567.
  • 21
    Weller M, Schmidt C, Roth W, Dichgans J. Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone? Neurology. 1997; 48: 1704-1709.
  • 22
    Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008; 10: R85.
  • 23
    Sterk V, Buchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med. 2004; 70: 1155-1160.
  • 24
    Wettergren L, Kettis-Lindblad A, Sprangers M, Ring L. The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW. Qual Life Res. 2009; 18: 737-746.